Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 07 2023
Historique:
received: 02 11 2022
accepted: 03 07 2023
medline: 10 7 2023
pubmed: 9 7 2023
entrez: 8 7 2023
Statut: epublish

Résumé

Polyphosphate (poly-P) biosynthesis in bacteria has been linked to many physiological processes and has been characterized as an interesting functional molecule involved in intestinal homeostasis. We determined the capacity for poly-P production of 18 probiotic strains mainly belonging to Bifidobacterium and former Lactobacillus genera, showing that poly-P synthesis varied widely between strains and is dependent on the availability of phosphate and the growth phase. Bifidobacteria were especially capable of poly-P synthesis and poly-P kinase (ppk) genes were identified in their genomes together with a repertoire of genes involved in phosphate transport and metabolism. In Bifidobacterium longum KABP042, the strain we found with highest poly-P production, variations in ppk expression were linked to growth conditions and presence of phosphate in the medium. Moreover, the strain produced poly-P in presence of breast milk and lacto-N-tetraose increased the amount of poly-P synthesized. Compared to KABP042 supernatants low in poly-P, exposure of Caco-2 cells to KABP042 supernatants rich in poly-P resulted in decreased epithelial permeability and increased barrier resistance, induction of epithelial protecting factors such as HSP27 and enhanced expression of tight junction protein genes. These results highlight the role of bifidobacteria-derived poly-P as a strain-dependent functional factor acting on epithelial integrity.

Identifiants

pubmed: 37422465
doi: 10.1038/s41598-023-38082-0
pii: 10.1038/s41598-023-38082-0
pmc: PMC10329679
doi:

Substances chimiques

Polyphosphates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11076

Informations de copyright

© 2023. The Author(s).

Références

Microorganisms. 2014 Mar 28;2(2):92-110
pubmed: 27682233
DNA Res. 2012 Oct;19(5):383-94
pubmed: 22923697
BMC Genomics. 2018 Jan 8;19(1):33
pubmed: 29310579
Benef Microbes. 2018 Feb 27;9(2):231-238
pubmed: 29488411
Ann Nutr Metab. 2017;70(3):184-190
pubmed: 28301837
Sci Rep. 2019 Mar 19;9(1):4879
pubmed: 30890726
PLoS One. 2011;6(8):e23278
pubmed: 21858054
Appl Environ Microbiol. 2002 Dec;68(12):6051-8
pubmed: 12450828
Probiotics Antimicrob Proteins. 2009 Dec;1(2):121
pubmed: 26783166
Appl Environ Microbiol. 2012 Aug;78(15):5258-69
pubmed: 22635988
J Fluoresc. 2008 Sep;18(5):859-66
pubmed: 18210191
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Appl Environ Microbiol. 2014 Mar;80(5):1650-9
pubmed: 24375133
Am J Gastroenterol. 2006 Jul;101(7):1581-90
pubmed: 16863564
World J Gastroenterol. 2012 Aug 14;18(30):4012-8
pubmed: 22912552
Appl Environ Microbiol. 2002 Aug;68(8):4107-10
pubmed: 12147514
Transl Res. 2015 Aug;166(2):163-75
pubmed: 25766132
Ann N Y Acad Sci. 2014 Feb;1309:1-18
pubmed: 24571253
Biosci Biotechnol Biochem. 2016 May;80(5):955-61
pubmed: 26966939
Biochem Biophys Res Commun. 2015 Nov 20;467(3):541-8
pubmed: 26459590
Dig Dis Sci. 2021 Nov;66(11):3872-3884
pubmed: 33492535
PLoS One. 2016 Sep 22;11(9):e0163216
pubmed: 27657913
PLoS One. 2016 Mar 08;11(3):e0150775
pubmed: 26953798
Pediatrics. 2018 Jan;141(1):
pubmed: 29279326
Clin Pharmacol Ther. 2020 Feb;107(2):452-461
pubmed: 31513280
Saudi J Biol Sci. 2021 Oct;28(10):5684-5692
pubmed: 34588880
PLoS One. 2017 Jun 8;12(6):e0179242
pubmed: 28594955
Annu Rev Biochem. 2009;78:605-47
pubmed: 19344251
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):821-834
pubmed: 28650209
Ann N Y Acad Sci. 2009 May;1165:183-9
pubmed: 19538305
Curr Microbiol. 2020 Sep;77(9):1987-1996
pubmed: 32472262
Int J Food Microbiol. 2011 Jan 31;145(1):320-5
pubmed: 21185614
J Biol Chem. 2013 Aug 30;288(35):25194-25206
pubmed: 23843461
Nutrients. 2019 Dec 26;12(1):
pubmed: 31888048
Nutrients. 2019 Aug 09;11(8):
pubmed: 31405051
Front Microbiol. 2022 Jan 12;12:741391
pubmed: 35095783
PLoS One. 2012;7(12):e50777
pubmed: 23236393
Front Microbiol. 2018 Sep 07;9:1944
pubmed: 30245671
Microb Cell Fact. 2020 Feb 5;19(1):23
pubmed: 32024520
J Clin Gastroenterol. 2019 Mar;53 Suppl 1:S1-S41
pubmed: 30741841
Annu Rev Biochem. 1999;68:89-125
pubmed: 10872445
Biochemistry (Mosc). 2000 Mar;65(3):304-8
pubmed: 10739472
Food Chem Toxicol. 2022 Aug;166:113224
pubmed: 35700822
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14
pubmed: 24912386
J Bacteriol. 1963 Oct;86:885-7
pubmed: 14066494
Sci Rep. 2015 Oct 28;5:15782
pubmed: 26506949
Nucleic Acids Res. 2016 Jan 4;44(D1):D286-93
pubmed: 26582926
Nucleic Acids Res. 2018 Jul 2;46(W1):W95-W101
pubmed: 29771380

Auteurs

Cristina Alcántara (C)

Laboratorio de Bacterias Lácticas y Probióticos, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), 46980, Paterna, Valencia, Spain.

Marta Perez (M)

R&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.

Pol Huedo (P)

R&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.

Tatiana Altadill (T)

R&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.
Basic Sciences Department, Universitat Internacional de Catalunya, Barcelona, Spain.

Jordi Espadaler-Mazo (J)

R&D Department, AB-Biotics S.A. (Part of Kaneka Corporation), Barcelona, Spain.

Juan Luis Arqués (JL)

Departamento de Tecnología de Alimentos, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA-CSIC), Madrid, Spain.

Manuel Zúñiga (M)

Laboratorio de Bacterias Lácticas y Probióticos, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), 46980, Paterna, Valencia, Spain.

Vicente Monedero (V)

Laboratorio de Bacterias Lácticas y Probióticos, Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), 46980, Paterna, Valencia, Spain. btcmon@iata.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH